Find industry news, trends, and innovative products right here in our blog.
A
B
C
D
E
G
H
I
J
L
M
N
O
P
R
S
T
U
V
W
X
Compare Tirzepatide vs Semaglutide insulin secretion mechanisms, including GLP-1R selectivity, GIPR co-activation, SURPASS-2 beta-cell data, and clamp findings for research.
Compare AOD-9604 vs Semaglutide across direct adipocyte lipolysis and GLP-1R appetite signaling, IGF-1 impact, and study-design fit for fat loss pathway research.
What is a defensible Botox price? Med Supply Solutions explains how sourcing, storage, vial handling, and unit costs shape the patient fee.
Compare AOD-9604 vs Tesamorelin in fat-reduction research: direct adipocyte lipolysis, GHRH-driven GH release, IGF-1 signaling, and visceral fat data.
Compare Ipamorelin vs GHRP-6 in preclinical research: GHS-R1a selectivity, cortisol and appetite differences, and pulsatile GH pulse amplitude data.
A research-focused comparison of Retatrutide vs Mazdutide, contrasting triple- and dual-receptor architecture, hepatic vs systemic endpoints, and current Phase 2/3 evidence.
Semaglutide vs Tirzepatide research: compare GLP-1 vs dual GLP-1/GIP receptor agonism, SURMOUNT and SUSTAIN outcomes, and protocol design considerations.
Tirzepatide vs Retatrutide in obesity and metabolic research: how triple GLP-1/GIP/glucagon receptor agonism differs from dual incretin activation.
Compare CJC-1295 vs Tesamorelin as GHRH analogues in visceral fat and metabolic research, with phase III VAT data, IGF-1 kinetics, and protocol notes.
Cagrilintide vs semaglutide research: how amylin and GLP-1 pathways drive satiety, why they combine in CagriSema, and what REDEFINE 1 showed at 68 weeks.
CJC-1295 vs Sermorelin compared for GHRH research: half-life, GH pulsatility, IGF-1 exposure, and endpoint selection for laboratory study design.
Compare Aliaxin vs Restylane, two popular dermal fillers, by exploring their similarities, differences, and ideal applications.
Subscribe for exclusive offers and updates on new arrivals